Sex Differences in Opioid-Induced Enhancement of Contact Hypersensitivity

Journal of Investigative Dermatology

Volumn 121, Issue 5, 2003, Pages 1053-1059

  Elliott, Jay C ^a   Picker, Mitchell J ^a   Nelson, Christina J ^a   Carrigan, Kelly A ^a   Lysle, Donald T ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Buprenorphine; Contact dermatitis; Etorphine; Morphine

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; BETA FUNALTREXAMINE; BUPRENORPHINE; ETORPHINE; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; OPIATE; SEX HORMONE;

ANIMAL MODEL; ARTICLE; CASTRATION; CONTACT ALLERGY; CONTACT DERMATITIS; CONTROLLED STUDY; DRUG POTENTIATION; EXTERNAL EAR; FEMALE; MALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SURFACE PROPERTY;

EID: 0242574326     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12569.x     Document Type: Article

References (41)

1. Aceto MD, Harris LS, Bowman ER: Etorphines: μ-Opioid receptor-selective antinocoception and low physical dependence capacity. Eur J Pharmacol 338:215-223, 1997
2. Baadsgaard O, Wang T: Immune regulation in allergic and irritant skin reactions. Int J Dematol 30:161-172, 1991
3. Baumann MH, Elmer GI, Goldberg SR, Ambrosio E: Differential neuroendocrine responsiveness to morphine in Lewis, Fischer 344, and ACI inbred rats. Brain Res 858:320-326, 2000
4. Bour H, Peyron E, Gaucherand M, et al: Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzenc. Eur J Immunol 25:3006-3010, 1995
5. Cher DJ, Mosmann T: Two types of murine helper T cell clone II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 138:3688-3694, 1987
6. Cicero TJ, Nock B, Meyer ER: Gender-linked differences in the expression of physical dependence in the rat. Pharmacol Biochem Behav 72:691-697, 2002
7. Cicero TJ, Nock B, Meyer ER: Gender-related differences in the antinociceptive properties of morphine. J Pharmacol Exp Ther 279:767-773, 1996
8. Cook CD, Barrett AC, Roach EL, Bowman JR, Picker MJ: Sex-related differences in the antinociceptive effects of opioids: Importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor. Psychopharmacology (Berlin) 150:430-442, 2000
9. Di Bello MG, Masini E, Ioannides C, Fomusi NJ, Raspanti S, Bani ST, Man naioni PF: Histarnine release from rat mast cells induced by the metabolic activation of drugs of abuse into free radicals. Inflamm Res 47:122-130, 1998
10. Eisenstein TK, Hilburger ME: Opioid modulation of immune responses: Effects on phagocyte and lymphoid cell populations. J Neuroimmunol 83:36-44, 1998
11. Emerson PJ, Liu MR, Woods JH, Medzihradsky F: Bunding affinites and selectivity of opioids at mu, delta, and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther 271:1630-1637, 1994
12. Enk AH, Katz SI: Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89:1398-1402, 1992
13. Fecho K, Maslonek KA, Coussons-Read ME, Dykstra LA, Lysle DT: Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J Immunol 152:5845-5852, 1994
14. Gades NM, Danneman PJ, Wixson SK, Toley EA: The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. Contamp Top Lab Anim Sci 39:8-13, 2000
15. Grabbe S, Schwarz T: Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 19:37-44, 1998
16. Holzer P: Peptidergic sensory neurons in the control of vascular functions: Mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev Physiol Biochem Pharmacol 121:49-146, 1992
17. Kirk RE: Experimental Design: Procedures for the Behavioral Sciences. Belmont (CA): Wadsworth, 1982
18. Kondo S, Pastore S, Fujisawa H, Shivji GM, McKenzie RC, Dinarello CA, Sauder DN: Interleukin-1 receptor antagonist suppresses contact hypersensitivity. J Invest Dermatol 105:334-338, 1995
19. Leposavic G, Karapetrovic B, Obradovic S, Vidiic DB, Kosec D: Differential effects of gonadectomy on the thymocyte phenotypic profile in male and female rats. Pharmacol Biochem Behav 54:269-276, 1996
20. Lysle DT, Coussons ME, Watts VJ, Bennet EH, Dykstra LA: Morphine-induced alterations of immune status: Dose dependency, compartment specificity and antagonism by naltrexone. J Pharmacol Exp Ther 265:1071-1078, 1993
21. Marks JG: Contact and Occupational Dermatology, (3rd ed). St. Louis: Mosby, 2002
22. Marone G, Stellato C, Mastronardi P, Mazzarella B: Mechanisms of activation of human mast cells and basophils by general anesthetic drugs. Ann Fr Anesth Reanim 12:116-125, 1993
23. McHale JF, Harari OA, Marshall D, Haskard DO: Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: Evidence for a dominant role of TNF-alpha. J Immunol 162:1648-1655, 1999
24. McMurray RW: Estrogen, prolactin, and autoimmunity: Actions and interactions. Int Immunopharmacol 1:995-1008, 2001
25. Mellon RD, Bayer BM: Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action. J Neuroimmunol 83:19-28, 1998
26. Negus SS, Dykstra LA: Kappa antagonist properties of buprenorphine in the Shock titration procedure. Eur J Pharmacol 156:77-86, 1988
27. Nelson CJ, How T, Lysle DT: Enhancement of the contact hypersensitivity reaction by acute morphine administration at the elicitation phase. Clin Immunol 93:176-183, 1999
28. Nelson CJ, Lysle DT: Involvement of substance P and central opioid receptors in morphine modulation of the CHS response. J Neuroimmunol 115:101-110, 2001a
29. Nelson CJ, Lysle DT: Morphine modulation of the contact hypersensitivity response: Characterization of immunological changes. Clin Immunol 98:370-377, 2001b
30. Niizeki H, Kurimoto I, Streilein JW: A substance P agonist acts as an adjuvant to promote hapten-specific skin immunity. J Invest Dermatol 112:437-442, 1999
31. Ray MC, Tharp MD, Sullivan TJ, Tigelaar RE: Contact hypersensitivity reactions to dinitrofluorobenzene mediated by monoclonal IgE anti-DNP antibodies. J Immnol 131:1096-1102, 1983
32. Rees JL, Fricdmann PS, Matthews JN: Sex differences in susceptibility to development of contact hypersensitivity to dinitrochlorobenzene (DNCB). Br J Dermatol 120:371-374, 1989
33. Sarton E, Olofsen E, Romberg R, et al: Sex differences in morphine analgesia: An experimental study in healthy volunteers. Anesthesiology 93:1245-1254, 2000
34. Sarton E, Teppema L, Dahan A: Sex differences in morphine-induced ventilatory depression reside within the peripheral chemoreflex loop. Anesthesiology 90:1329-1338, 1999
35. Shaar CJ, Euker JS, Riegle GD, Meites J: Effects of castration and gonadal steroids on serum luteinizing hormone and prolactin in old and young rats. J Endocrinol 66:45-51, 1975
36. Terner JM, Barrett AC, Grossell E, Picker MJ: Influence of gonadectomy on the antinociceptive effects of opioids in male and female rats. Psychopharmacology (Berlin) 163:183-193, 2002
37. Travi BL, Osorio Y, Melby PC, Chandrasekar B, Arteaga L, Saravia NG: Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp. Inject Immun 70:2288-2296, 2002
38. Tzschentke TM: Behavioral pharmacology of buprenorphine, with a focus on preclinical models of reward and addiction. Psychopharmacology (Berlin) 16:1-16, 2002
39. Whitacre CC, Reingold SC, O'Looney PA: A gender gap in autoimmunity. Science 283:1277-1278, 1999
40. Xu H, Dilulio NA, Fairchild RL: T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (II) 4/11-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 183:1001-1012, 1996
41. Zun LS, Downey LV, Gossman W, Rosenbaumdagger J, Sussman G: Gender differences in narcotic-induced emesis in the ED. Am J Emerg Med 20:151-154, 2002